Custodero et al. conclude that N-terminal pro-brain natriuretic peptide (NT-proBNP) levels during the acute phase of sepsis may be a useful indicator of higher risk of long-term impairments in physical function and muscle strength in sepsis survivors [1] . A letter from Jiarong et al. has challenged this assertion, pointing to the exponential increase in the plasma level of NT-proBNP with a declining glomerular filtration rate. As they have noted, it does not seem persuasive that NT-proBNP could completely predict outcomes without adjusting for the covariate of renal function. They suggest that the relationship of NT-proBNP levels during the acute phase of sepsis and physical function and muscle strength outcomes in sepsis survivors be stratified based on the renal function [2] . In keeping with this, we would like to comment further. Nearly half of critically ill patients, especially with septic shock, have or develop acute kidney injury (AKI) and 20-25% need renal replacement therapy (RRT) within the first week of their stay [3] . In the Custodero study, the two cohorts (chronic critical illness [CCI] and rapid recovery [RAP]) had a considerable difference in the incidence of septic shock (36.5% vs 16.4%), so it would stand to reason that the rate of AKI and continuous renal replacement therapy (CRRT) was much lower in the RAP cohort when compared to the CCI cohort [1] . CRRT is performed using membranes that have a cut-off value of 35-40 kDa and therefore some quantity of NT-proBNP will be eliminated [4] . Because of its low molecular weight (8.5 kDa), NT-proBNP is likely to be effectively cleared by both high-and low-flux membranes [4] . New highly adsorptive membranes (HAM) can adsorb many molecules with a molecular weight above 35 kDa and will increase this removal even further [4] . This could mislead patient prognostication by artificially decreasing NT-proBNP, but no studies have challenged this issue. Such studies should be done as there is already a long list of biomarkers in sepsis that are lacking reliability during CRRT [5] . As a consequence of the different rates of CRRT between the two cohorts, the reliability of NT-proBNP to be a useful indicator of long-term impairments in physical function and muscle strength in sepsis survivors might be questioned.
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Authors' response
Our primary purpose of showing this predictive association was to continue this line of research to further understand the biology of high NT-proBNP levels in acute phase of sepsis and as a novel approach to potentially identify sepsis patients at high risk for functional decline. Therefore, we agree with the authors that other factors such as CRRT in artificially decreasing the NT-proBNP levels should be taken into consideration in our future investigations to further explore the biological factors that may underlie high NT-proBNP levels in the acute sepsis patient population.
Abbreviations NT-proBNP: N-terminal pro-brain natriuretic peptide; CCI: Chronic critical illness; RAP: Rapid recovery; ICU: Intensive care unit; AKI: Acute kidney injury; RRT: Renal replacement therapy; CRRT: Continuous renal replacement therapy; HAM: Highly adsorptive membranes
